Imagine a cancer treatment that precisely targets malignant cells, leaving healthy ones untouched. Consider, also, a cancer treatment that corrects abnormal protein synthesis to produce healthy ...

This article explores limitations of chemical synthesis in high-throughput settings and the technical advantages enzymatic ...

Within a cell, DNA carries the genetic code for building proteins. To build proteins, the cell makes a copy of DNA, called mRNA. Then, another molecule called a ribosome reads the mRNA, translating it ...

Unlocking the potential of mRNA technology is helping revolutionize medicine and biotechnology. Solid-phase in vitro transcription enables scalability and automation, helping make it a valuable tool ...

Creative Biolabs optimizes the mRNA drug development model by integrating sequence design, RNA-protein interaction ...

The COVID-19 pandemic thrust messenger RNA (mRNA) into the spotlight, underscoring its promise as a nimble, programmable platform for delivering genetic instructions directly to cells. The success of ...

RNA-based therapeutics are transforming medicine, but scaling production efficiently remains a challenge, particularly the cost-intensive in vitro transcription (IVT) step. Join this webinar to ...

Changing just one atom in a COVID-19 vaccine lipid redirects delivery from the liver to the spleen, improving tumor ...

New Delhi: American developmental biologist Victor R. Ambros and fellow molecular biologist Gary Bruce Ruvkun were awarded the 2024 Nobel Prize in Physiology or Medicine Monday. They won the award for ...

Researchers at LMU have uncovered how ribosomes, the cell’s protein builders, also act as early warning sensors when ...